Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Daiichi claims pyrazole derivatives as antitumor agents

March 7, 2000

New epipodophyllotoxin anticancer agent reported; studies on mechanism of action described

March 7, 2000

Structure elucidation, biological activity of a novel antimitotic agent: FR-182877

March 7, 2000

Squalamine enters combination trials with cisplatin for advanced cancer

March 7, 2000

Immunomedics updates progress with genetically engineered cancer immunotherapy

March 6, 2000

First report of sequence-specific DNA dialkylation with diamide-CPI conjugate

March 6, 2000

Triapine anticancer therapy completes phase I trial

March 3, 2000

Schedule-dependent antitumor activity demonstrated for new modified steroidal lactams

March 3, 2000

ADIR's new MMP inhibitors particularly useful for cancer, rheumatoid arthritis

March 3, 2000

Pharmachemie presents new water-soluble tin compounds with excellent antitumor activity

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...